go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

Boehringer Ingelheim Ltd Consumer Healthcare

Boehringer Ingelheim Ltd Consumer Healthcare
Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS, UK
Summary of Product Characteristics last updated on medicines.ie: 09/05/2012
SPC Dulcolax 5 mg Gastro-resistant Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 09/05/2012 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.2 - Posology and method of administration
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   01-Apr-2012
Legal Category:   Supply through pharmacy only

Free-text change information supplied by the pharmaceutical company



Section 4.2 Posology and Method of Administration

The penultimate paragraph of this section has been amended with text both added to and deleted from.  The text … , but in some cases it may take up to 45 minutes has been added and the text … (range 10 to 30 minutes) has been deleted.

 

Section 5.2 Pharmacokinetic Properties

This whole section has been amended, with text both added to and deleted from.  The first paragraph has had mainly text deleted from, but has also had some text added to.

 

The text of what are now the second and third paragraphs of this section is mainly new text.

 

The text of what were previously the last four paragraphs of this section has been deleted.

 

Section 10 Date of Revision of the Text

The date has been amended from June 2011 to April 2012.

Updated on 28/06/2011 and displayed until 09/05/2012
Reasons for adding or updating:
  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   01-Jun-2011
Legal Category:   Supply through pharmacy only

Free-text change information supplied by the pharmaceutical company



Section 1 Name of the Medicinal Product

The text … Gastro-resistant has been added to and the strength text moved in this section i.e. to now read Dulcolax 5 mg Gastro-resistant Tablets as opposed to Dulcolax Tablets 5 mg.

 

Section 2 Qualitative and Quantitative Composition

The word Excipients and text regarding Lactose monohydrate and Sucrose has been added to this section.

 

The words … a full list of have been added to the final sentence of this section to now read: For a full list of excipients, see section 6.1.

 

Section 3 Pharmaceutical Form

The text … (tablet) has been added to the first sentence of this section.

 

Section 4.4 Special Warnings and Precautions for Use

The text … galactose intolerance, the Lapp Lactase deficiency has been added to the final paragraph of this section.

Section 10 Date of Revision of the Text

The date has been updated from March 2011 to June 2011.

Updated on 05/04/2011 and displayed until 28/06/2011
Reasons for adding or updating:
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   01-Mar-2011
Legal Category:   Supply through pharmacy only

Free-text change information supplied by the pharmaceutical company



Section 4.6 Fertility, Pregnancy and Lactation

A new final sentence/paragraph has been added to the Lactation paragraph of this section i.e. No studies on the effect on human fertility have been conducted.

 

Section 4.7 Effects on Ability to Drive and Use Machines

A new second/final paragraph regarding vasovagal response and dizziness/syncope has been added to this section.

 

Section 4.8 Undesirable Effects

A new first sentence/paragraph regarding abdominal pain and diarrhoea has been added to this section.

 

The text Not known – incidence cannot be estimated from the available data has been deleted from the Adverse events have been ranked under headings of frequency paragraph. 

 

This complete section has been reworded, with text being both added to and deleted from.

 

A new sub-heading, Nervous system disorders, has been added.

 

Section 10 Date of Revision of the Text

The date has been updated from January 2011 to March 2011.

Updated on 21/01/2011 and displayed until 05/04/2011
Reasons for adding or updating:
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   01-Jan-2011
Legal Category:   Supply through pharmacy only

Free-text change information supplied by the pharmaceutical company



Section 4.2 Posology and Method of Administration

This section has been reworded.  Three of the original paragraphs remain the same, the rest of the section’s text is new.

 

Section 4.6 Pregnancy and Lactation

The header of this section has been amended to now read Fertility, pregnancy and lactation as opposed to Pregnancy and lactation.

 

Section 5.1 Pharmacodynamic Properties

This section has been reworded, with text being both added and deleted.

 

Section 5.2 Pharmacokinetic Properties

This section has been reworded, with text being both added and deleted.

 

Section 10 Date of Revision of the Text

The date has been updated from June 2010 to January 2011.

Updated on 01/07/2010 and displayed until 21/01/2011
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   01-Jun-2010
Legal Category:   Supply through pharmacy only

Free-text change information supplied by the pharmaceutical company



Section 4.4 Special Warnings and Precautions for Use

New third and fourth paragraphs have been added to this section regarding intestinal loss of fluids and haematochezia (blood in stool).

 

The paragraph commencing with the text Dizziness and / syncope has been amended with both text being deleted from and added to. 

 

Section 4.6 Pregnancy and Lactation

This section has been completely re-written, with the exception of the final paragraph,  with separate sub-headings regarding Pregnancy and Lactation.

 

The word DULCOLAX in the final paragraph of this section has been replaced with the word bisacodyl and the following text has been deleted from this paragraph:

 

… in pregnancy, especially the first trimester

 

Section 4.8 Undesirable Effects

The following text has been added to the Immune system disorders sub-heading of this section:

 

Rare: hypersensitivity

 

The second sentence of the Immune system disorders sub-heading has been amended to now read:

 

Not known: anaphylactic reactions, angioedema

 

i.e. deletion of the words neurotic and other hypersensitivity

 

A new sub-heading regarding Metabolism and nutrition disorders has been added to this section.

 

The following text has been added to the Uncommon sentence of the Gastrointestinal disorders sub-heading of this section:

 

…, haematochezia (blood in stool), abdominal discomfort, anorectal discomfort

 

The words Abdominal discomfort have been deleted from the Common sentence of the Gastrointestinal disorders sub-heading of this section.

 

Section 4.9 Overdose

The first paragraph of this section has been amended to include the text watery stools, brackets round the word diarrhoea and the text fluid.

 

The first paragraph of the Therapy sub-heading has had the text or gastric lavage added to the end of the first sentence.

 

The text Within a short time, Otherwise gastric lavage should be performed and (particularly hypokalaemia) has been deleted from the first paragraph of the Therapy sub-heading.

 

The word some has been deleted from between the words of and value in the second paragraph of the Therapy sub-heading of this section.

 

Section 10 Date of Revision of the Text

The date has been updated to June 2010.

Updated on 12/05/2010 and displayed until 01/07/2010
Reasons for adding or updating:
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   01-Apr-2010
Legal Category:   Supply through pharmacy only

Free-text change information supplied by the pharmaceutical company



Section 4.7 Effects on Ability to Drive and Use Machines

The following text:

 

None stated.

 

has been replaced with the following text:

 

No studies on the effects of DULCOLAX on the ability to drive and use machines have been performed.

 

Section 10 Date of Revision of the Text

The date has been updated from January 2009 to April 2010.

Updated on 15/07/2009 and displayed until 12/05/2010
Reasons for adding or updating:
  • New SPC for new product
Date of revision of text on the SPC:  
Legal Category:   Supply through pharmacy only

Free-text change information supplied by the pharmaceutical company

None provided

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Bisacodyl

Versions

 
09/05/2012 to Current
28/06/2011 to 09/05/2012
05/04/2011 to 28/06/2011
21/01/2011 to 05/04/2011
01/07/2010 to 21/01/2011
12/05/2010 to 01/07/2010
15/07/2009 to 12/05/2010
  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo